IL6 and cancer: It is also known that IL-6 participates in the regulation of migration and invasiveness of several types of cancer cells [15], including nasopharyngeal carcinoma cells, in which blocking of the IL-6 receptor by a specific monoclonal antibody reversed both processes and also EMT [65].